2005
DOI: 10.1212/01.wnl.0000178984.30534.f9
|View full text |Cite
|
Sign up to set email alerts
|

MRI as a marker for disease heterogeneity in multiple sclerosis

Abstract: The inflammatory activity and destructiveness of the multiple sclerosis process are to some degree independent of each other, and the successive evaluation of both of these variables can strengthen prediction of clinical outcome in individual patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
57
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 66 publications
(60 citation statements)
references
References 33 publications
3
57
0
Order By: Relevance
“…3 Recently, the heterogeneity of MS was also dissected in vivo using non-invasive magnetic resonance imaging (MRI) techniques combined with statistical remodeling. 4 Although in this study the MRI data could not be correlated with pathological data, the observed subgroups were clinically meaningful. The existence of heterogeneity in the brain of MS patients is proposed to reflect different pathogenic processes underlying MS: 3 an inflammation-mediated and an immune-independent demyelinating form, which both ultimately might drive brain tissue destruction.…”
Section: Introductionmentioning
confidence: 72%
“…3 Recently, the heterogeneity of MS was also dissected in vivo using non-invasive magnetic resonance imaging (MRI) techniques combined with statistical remodeling. 4 Although in this study the MRI data could not be correlated with pathological data, the observed subgroups were clinically meaningful. The existence of heterogeneity in the brain of MS patients is proposed to reflect different pathogenic processes underlying MS: 3 an inflammation-mediated and an immune-independent demyelinating form, which both ultimately might drive brain tissue destruction.…”
Section: Introductionmentioning
confidence: 72%
“…An inverse relation between BPF and disability progression has repeatedly been demonstrated [11,12]. Further, MRI-based stratification by the amount of inflammatory lesions and the extent of both global and focal brain atrophy during consecutive, monthly MRI scans has been used to dissect disease heterogeneity in MS [13]. Interestingly, disease progression over time was most pronounced in the subgroup with both high inflammation and degenerative changes [13].…”
Section: Introductionmentioning
confidence: 98%
“…Further, MRI-based stratification by the amount of inflammatory lesions and the extent of both global and focal brain atrophy during consecutive, monthly MRI scans has been used to dissect disease heterogeneity in MS [13]. Interestingly, disease progression over time was most pronounced in the subgroup with both high inflammation and degenerative changes [13]. Assessing atrophy parameters employs three-dimensional MRI sequences and segmentation algorithms, that are, however, time consuming and not easily accessible in routine clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…4,12 In fact, signs of strong tissue destruction may occur during the course of MS despite low cumulative inflammatory activity. 13 The strong clinical relevance of brain volumetry in MS is supported by correlations between baseline brain volume and disability occurring 8 years later 14 and associations between early brain atrophy rates and clinical deterioration. 15 DWI detects alterations of microscopic diffusion processes in MS due to a variety of factors, including loss of myelin sheaths, loss of axonal membranes, neuronal apoptosis, and gliosis formation.…”
mentioning
confidence: 99%